Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.62%GBPCHF+0.52%AUDCHF+0.43%NZDCHF+0.41%GBPTRY+0.41%USDCAD-0.41%EURCAD-0.35%CADJPY+0.34%GBPHKD+0.32%GBPUSD+0.31%GBPMXN-0.28%AUDSGD+0.28%USDTRY+0.28%NZDSGD+0.27%EURCHF+0.27%CHFJPY-0.25%NZDUSD+0.24%GBPJPY+0.24%AUDUSD+0.23%EURGBP-0.22%USDNOK-0.21%NZDCAD-0.20%USDCHF+0.20%GBPSGD+0.20%NZDMXN+0.19%USDZAR-0.18%AUDCAD-0.18%EURSGD+0.17%AUDJPY+0.17%USDPLN-0.16%USDILS+0.16%CHFSGD+0.16%NZDJPY+0.16%USDSEK-0.16%NOKJPY+0.15%EURAUD-0.14%SGDJPY-0.13%EURNZD-0.12%CHFNOK-0.12%AUDDKK+0.11%EURHKD+0.11%USDDKK-0.11%EURNOK-0.11%PLNJPY+0.10%GBPAUD+0.09%GBPCAD-0.09%EURCNH+0.08%USDTHB+0.08%EURZAR-0.08%EURUSD+0.07%GBPNZD+0.07%USDSGD+0.06%CHFSEK-0.06%USDJPY-0.06%EURPLN-0.06%GBPZAR-0.05%EURSEK-0.05%USDCOP-0.04%USDCNH-0.02%EURJPY+0.02%AUDNZD+0.02%USDMXN-0.02%EURCZK+0.01%AUDNOK+0.01%USDHKD+0.01%EURDKK0.00%COTTON+1.01%HG1+0.72%XNGUSD+0.41%S1+0.40%UKOIL-0.28%USOIL-0.26%W1-0.24%XPTUSD-0.06%C1-0.05%XAGUSD+0.03%GAGUSD+0.03%XAUUSD0.00%BTCUSD+2.48%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.23%DOGEUSD+14.12%XMRUSDT+5.48%LINKUSD+13.42%XLMUSD+0.01%BCHUSDT+5.52%UNIUSD+7.15%LTCUSD+9.66%SUIUSD+3.18%HBARUSDT+0.31%TONUSD+26.15%TAOUSDT+3.43%AAVEUSD+3.37%DOTUSDT-0.28%ICPUSDT+0.04%ONDOUSDT+0.23%WLDUSDT-0.40%ARBUSDT+6.77%JUPUSDT+0.31%ATOMUSDT+1.34%INJUSDT+13.79%STXUSDT+5.54%FETUSDT+2.34%TIAUSDT+8.63%PYTHUSDT-1.20%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+19.70%GRTUSDT+3.68%IOTAUSDT+0.53%WIFUSDT+2.21%AXSUSDT-1.74%POLUSDT+2.69%FARTCOINUSDT+0.62%EOSUSDT+1.91%DYDXUSDT+3.35%GALAUSDT-2.32%ORDIUSDT-0.21%RONINUSDT-3.42%NOTUSDT+0.10%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.62%GBPCHF+0.52%AUDCHF+0.43%NZDCHF+0.41%GBPTRY+0.41%USDCAD-0.41%EURCAD-0.35%CADJPY+0.34%GBPHKD+0.32%GBPUSD+0.31%GBPMXN-0.28%AUDSGD+0.28%USDTRY+0.28%NZDSGD+0.27%EURCHF+0.27%CHFJPY-0.25%NZDUSD+0.24%GBPJPY+0.24%AUDUSD+0.23%EURGBP-0.22%USDNOK-0.21%NZDCAD-0.20%USDCHF+0.20%GBPSGD+0.20%NZDMXN+0.19%USDZAR-0.18%AUDCAD-0.18%EURSGD+0.17%AUDJPY+0.17%USDPLN-0.16%USDILS+0.16%CHFSGD+0.16%NZDJPY+0.16%USDSEK-0.16%NOKJPY+0.15%EURAUD-0.14%SGDJPY-0.13%EURNZD-0.12%CHFNOK-0.12%AUDDKK+0.11%EURHKD+0.11%USDDKK-0.11%EURNOK-0.11%PLNJPY+0.10%GBPAUD+0.09%GBPCAD-0.09%EURCNH+0.08%USDTHB+0.08%EURZAR-0.08%EURUSD+0.07%GBPNZD+0.07%USDSGD+0.06%CHFSEK-0.06%USDJPY-0.06%EURPLN-0.06%GBPZAR-0.05%EURSEK-0.05%USDCOP-0.04%USDCNH-0.02%EURJPY+0.02%AUDNZD+0.02%USDMXN-0.02%EURCZK+0.01%AUDNOK+0.01%USDHKD+0.01%EURDKK0.00%COTTON+1.01%HG1+0.72%XNGUSD+0.41%S1+0.40%UKOIL-0.28%USOIL-0.26%W1-0.24%XPTUSD-0.06%C1-0.05%XAGUSD+0.03%GAGUSD+0.03%XAUUSD0.00%BTCUSD+2.48%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.23%DOGEUSD+14.12%XMRUSDT+5.48%LINKUSD+13.42%XLMUSD+0.01%BCHUSDT+5.52%UNIUSD+7.15%LTCUSD+9.66%SUIUSD+3.18%HBARUSDT+0.31%TONUSD+26.15%TAOUSDT+3.43%AAVEUSD+3.37%DOTUSDT-0.28%ICPUSDT+0.04%ONDOUSDT+0.23%WLDUSDT-0.40%ARBUSDT+6.77%JUPUSDT+0.31%ATOMUSDT+1.34%INJUSDT+13.79%STXUSDT+5.54%FETUSDT+2.34%TIAUSDT+8.63%PYTHUSDT-1.20%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+19.70%GRTUSDT+3.68%IOTAUSDT+0.53%WIFUSDT+2.21%AXSUSDT-1.74%POLUSDT+2.69%FARTCOINUSDT+0.62%EOSUSDT+1.91%DYDXUSDT+3.35%GALAUSDT-2.32%ORDIUSDT-0.21%RONINUSDT-3.42%NOTUSDT+0.10%
QN

Qiagen N.V. (QGEN)

NYSE • Healthcare

$45.44
+$0.12 (+0.3%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$45.77
Day Range$44.97 - $45.79
Avg. Volume (3M)2.2M
Market Cap$9.3B
P/E Ratio23.3
52 Week Range
$32.53$57.82
Next EarningsIn 20 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$535M100%
Gross Profitminus cost of goods$340.3M64%
Operating Incomeminus R&D and overhead$132.4M25%
Net Incomeminus taxes and the rest$103.4M19%

In plain terms: out of every $100 in revenue, Qiagen N.V. keeps $19 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.1B
Net Income (TTM)
$409.3M
EPS (TTM)
$1.95
ROA (TTM)
6.95%
Current Ratio
2.85
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.6%Q1 2026$0.62
-0.4%Q2 2026$0.54
+3.7%Q3 2026$0.62
Next

Nov 3

in 20 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.7%

Qiagen N.V. topped consensus on both adjusted EPS and revenue based on preliminary results for the second fiscal quarter of 2026 reported on Aug. 5, with adjusted EPS of $0.62 versus the $0.60 estimate and revenue of about $535.0 million versus $527.5 million, or roughly 4% and about 1% ahead, respectively. Revenue was roughly flat year over year, up 0.3% to about $535.0 million, while net income increased 7.4% to about $103.4 million from $96.2 million a year ago. Gross profit of about $338.0 million left gross margin at 63.2%, and operating income came to about $140.8 million with operating margin of 26.3%. Operating cash flow was about $200.7 million. Consensus for the next period calls for EPS of $0.63 on revenue of $551.3 million.

Next report — what to expect

Qiagen N.V. (QGEN) is set to report earnings on November 3, 2026. Wall Street is looking for EPS of $0.62 on revenue of $535.9 million. For trailing context, revenue rose +0.3% year over year last quarter. Qiagen has beaten EPS in 6 of its 8 most recent quarters.

View full earnings history

About Qiagen N.V.

Qiagen N.V. (NYSE: QGEN) develops molecular testing and life-science tools for healthcare and research use, spanning diagnostic assays, laboratory consumables, instruments, and software. In FY2025, the company generated $2.1 billion in revenue. It serves the medical diagnostics and research market worldwide.

Name
Qiagen N.V.
CEO
Jon Pratt
Industry
Healthcare
Year Founded
1984
Employees
5,500

Today's Snapshot

AI-generated

The day ended with QGEN slightly higher at 45.46, while its sector was weaker. Volume was about half of its usual level.

Trading Volume

Below 10d avg (2.3M)

1.1M

vs S&P 500 Today

Moderate Outperformance

+0.35%

Updated: October 13, 2026 at 20:09 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
QGEN presents a broadly constructive setup with price trading above short- and longer-term moving averages and positive momentum evident in the MACD and momentum indicators, while RSI sits in a healthy mid-range. ADX is low, signaling that the uptrend lacks strong directional force, and volatility is modest with ATR under 1.5. Notably, on-balance volume is materially negative, which contrasts with price strength and suggests limited participation behind gains. Technical takeaway: Strong Buy — price structure and momentum are positive, though trend strength is muted and volume does not confirm fully.
All signals
  • EMA (5 indicators)$42.42 - $44.91
    Buy
  • RSI (14)56.64
    Neutral
  • Stochastic %K (14, 3, 3)64.36
    Neutral
  • MACD Level (12, 26)0.58
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.